Regulation of α1-, β1-, and β2-adrenergic receptors in rat heart by norepinephrine

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 5 40-5, 1996, Pages

  Zhao, Mingming ^a   Hagler, Herbert K ^a   Muntz, Kathryn H ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b Department of Geology and Environmental Science   (United States)

Author keywords

autoradiography; adrenergic receptor subtypes

Indexed keywords

5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ALPHA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; CYANOIODOPINDOLOL; ISOPRENALINE; NORADRENALIN; PRAZOSIN; PROPRANOLOL DERIVATIVE; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; AUTORADIOGRAPHY; CATECHOLAMINE BLOOD LEVEL; CORONARY ARTERY; DRUG RECEPTOR BINDING; HEART FAILURE; HEART MUSCLE CELL; MALE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION;

EID: 33750734739     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.5.h1762     Document Type: Article

References (34)

1. Beau, S. L., and J. E. Saffitz. Defective norepinephrine uptake in the subendocardium of failing human hearts (Abstract). Circulation 86, Suppl. I: I-665, 1993.
2. Beau, S. L., T. K. Tolley, and J. E. Saffitz. Heterogeneous transrmiral distribution of β-adrenergic receptor subtypes in failing human hearts. Circulation 88: 2501-2509, 1993.
3. 1-receptor downregulation in heart failure. Circ. Res. 59: 297-309, 1986.
4. Bristow, M. R., W. Minobe, R. Rasmussen, R. E. Hershberger, and B. B. Hoffman. Alpha-1-adrenergic receptors in the nonfailing and failing human heart. J. Pharmacol. Exp. Ther. 247: 1039-1045, 1988.
5. Bristow, M. R., W. Minobe, R. Rasmussen, P. Larrabee, L. Skerl, J. W. Klein, F. L. Anderson, J. Murray, S. V. Karwande, M. Fowler, and R. Ginsburg. β-Adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J. Clin. Invest. 89: 803-815, 1992.
6. Butterfield, M. C., and R. Chess-Williams. Potentiation of α-adrenoceptor-mediated responses following chronic β-adrenoceptor stimulation in the rat heart. Br. J. Pharmacol 108: 658-662, 1993.
7. Chidsey, C. A., E. Braunwald, and A. G. Morrow. Catecholamine excretion and cardiac stores of norepinephrine in congestive heart failure. Am. J. Med. 39: 442-451, 1965.
8. Downing, S. E., and J. C. Lee. Contribution of α-adrenoceptor activation to the pathogenesis of norepinephrine cardiomyopathy. Circ. Res. 52: 471-478, 1983.
9. 1-Adrenoceptors in myocardium: functional aspects and transmembrane signaling mechanisms. Physiol. Rev. 73: 469-487, 1993.
10. Gengo, P. J., N. Bowling, V. L. Wyss, and J. S. Hayes. Effects of prolonged phenylephrine infusion on cardiac adrenoceptors and calcium channels. J. Pharmacol. Exp. Ther. 244: 100-105, 1988.
11. Hadcock, J. R., and C. C. Malbon. Agonist regulation of gene expression of adrenergic receptors and G proteins. J. Neurochem. 60: 1-9, 1993.
12. Hasking, G. J., M. D. Esler, G. L. Jennings, D. Burton, and P. I. Korner. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73: 615-621, 1986.
13. Kenakin, T. P., and D. Beek. Is prenalterol (H133/80) really a selective beta-1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships. J. PharmacoL Exp. Ther. 213: 406-413, 1980.
14. Lu, X., and D. B. Barnett. Differential rates of down regulation and recovery of rat myocardial β-adrenoceptor subtypes in vivo. Eur J. Pharmacol. 182: 481-486, 1990.
15. McPherson, G. A., P. Molenaar, and E. Malta. The affinity and efficacy of naturally occurring catecholamines at β-adrenoceptor subtypes. J. Pharm. Pharmacol. 37: 499-501, 1985.
16. Molenaar, P., J. J. Smolich, F. D. Russell, L. R. McMartin, and R. J. Summers. Differential regulation of beta-1 and beta-2 adrenoceptors in guinea pig atrioventricular conducting system after chronic (-)-isoproterenol infusion. J. Pharmacol. Exp. Ther. 255: 393-400, 1990.
17. Mukherjee, A., T. M. Wong, L. M. Buja, R. J. Lefkowitz, and J. T. Willerson. Beta adrenergic and muscarinic cholinergic receptors in canine myocardium. Effects of ischemia. J. Clin. Invest. 64: 1423-1428, 1979.
18. 1-Receptor localization in rat heart and kidney using autoradiography. Am. J. Physiol. 249 (Heart Circ. Physiol. 18): H512-H519, 1985.
19. Muntz, K. H., M. Zhao, and J. C. Miller. Downregulation of myocardial β-adrenergic receptors: receptor subtype selectivity. Circ. Res. 74: 369-375, 1994.
20. Packer, M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 77: 721-730, 1988.
21. Rose, C. P., J. H. Burgess, and D. Cousineau. Reduced aortocoronary sinus extraction of epinephrine in patients with left ventricular failure secondary to long-term pressure or volume overload. Circulation 68: 241-244, 1983.
22. Snavely, M. D., L. C. Mahan, D. T. O'Connor, and P. A. Insel. Selective downregulation of adrenergic receptor subtypes in tissues from rats with pheochromocytoma. Endocrinology 113: 354-361, 1983.
23. 1-adrenoceptor densities in different mammalian species. Br. J. Pharmacol. 107: 185-188, 1992.
24. 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure. Br. J. Pharmacol. 105: 463-469, 1992.
25. 2-adrenergic receptors in Chinese hamster fibroblasts. Mol. Pharmacol. 41: 542-548, 1992.
26. 1-adrenoceptors: an overview. Pharmacol. Rev. 45: 147-175, 1993.
27. 1-adrenergic receptors on sarcolemma from normal subjects and patients with idiopatbic dilated cardiomyopathy: characteristics and linkage to GTP-binding protein. Circ. Res. 64: 474-481, 1989.
28. Valet, P., J.-L. Montastruc, M. Berlan, M.-A. Tran, M. Lafontan, and P. Montastruc. Differential regulation of fat cell beta-2 and beta-1 adrenoceptors by endogenous catecholamines in dog. J. Pharmacol. Exp. Ther. 249: 271-277, 1989.
29. Vatner, D. E., S. F. Vatner, J. Nejima, N. Uemura, E. E. Susanni, T. H. Hintze, and C. J. Homey. Chronic norepinephrine elicits desensitization by uncoupling the β-receptor. J. Clin. Invest. 84: 1741-1748, 1989.
30. Vatner, S. F., C. B. Higgins, and E. Braunwald. Effects of norepinephrine on coronary circulation and left ventricular dynamics of the conscious dog. Circ. Res. 34: 812-823, 1974.
31. Von Euler, U. S., and F. Lishajko. The uptake of isoprenaline in nerve granules. Int. J. Neuropharmacol. 6: 431-434, 1980.
32. Warner, M. R., P. D. Senannayake, C. M. Ferrario, and M. N. Levy. Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart. Circ. Res. 69: 455-465, 1991.
33. Weibel, E. R. Sterological Methods. Practical Methods for Biological Morphometry. New York. Academic, 1979, vol. I.
34. 2-adrenergic receptors in tissue compartments of rat heart is not altered by sympathetic denervation. Circ. Res. 73: 943-951, 1993.